» Articles » PMID: 28118827

Monitoring Travellers from Ebola-affected Countries in New South Wales, Australia: What is the Impact on Travellers?

Overview
Publisher Biomed Central
Specialty Public Health
Date 2017 Jan 26
PMID 28118827
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Amidst an Ebola virus disease (EVD) epidemic of unprecedented magnitude in west Africa, concerns about the risk of importing EVD led to the introduction of programs for the screening and monitoring of travellers in a number of countries, including Australia. Emerging reports indicate that these programs are feasible to implement, however rigorous evaluations are not yet available. We aimed to evaluate the program of screening and monitoring travellers in New South Wales.

Methods: We conducted a mixed methods study to evaluate the program of screening and monitoring travellers in New South Wales. We extracted quantitative data from the Notifiable Conditions Information Management System database and obtained qualitative data from two separate surveys of public health staff and arrivals, conducted by phone.

Results: Between 1 October 2014 and 13 April 2015, public health staff assessed a total of 122 out of 123 travellers. Six people (5%) developed symptoms compatible with EVD and required further assessment. None developed EVD. Aid workers required lower levels of support compared to other travellers. Many travellers experienced stigmatisation. Public health staff were successful in supporting travellers to recognise and manage symptoms.

Conclusion: We recommend that programs for monitoring travellers should be tailored to the needs of different populations and include specific strategies to remediate stigmatisation.

Citing Articles

Public health information on COVID-19 for international travellers: lessons learned from a mixed-method evaluation.

Zhang T, Robin C, Cai S, Sawyer C, Rice W, Smith L Public Health. 2021; 193:116-123.

PMID: 33780897 PMC: 7874910. DOI: 10.1016/j.puhe.2021.01.028.


Airport Entry and Exit Screening during the Ebola Virus Disease Outbreak in Sierra Leone, 2014 to 2016.

Wickramage K Biomed Res Int. 2020; 2019:3832790.

PMID: 31915689 PMC: 6930773. DOI: 10.1155/2019/3832790.


Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact.

Mouchtouri V, Christoforidou E, An der Heiden M, Menel Lemos C, Fanos M, Rexroth U Int J Environ Res Public Health. 2019; 16(23).

PMID: 31766548 PMC: 6926871. DOI: 10.3390/ijerph16234638.


Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion.

Pleet M, DeMarino C, Stonier S, Dye J, Jacobson S, Aman M Viruses. 2019; 11(5).

PMID: 31052499 PMC: 6563240. DOI: 10.3390/v11050410.


Qualitative study of Ebola screening at ports of entry to the UK.

Kesten J, Audrey S, Holding M, Coope C, Young N, Brown C BMJ Glob Health. 2018; 3(3):e000788.

PMID: 29989094 PMC: 6035509. DOI: 10.1136/bmjgh-2018-000788.

References
1.
Tracey L, Regan A, Armstrong P, Dowse G, Effler P . EbolaTracks: an automated SMS system for monitoring persons potentially exposed to Ebola virus disease. Euro Surveill. 2015; 20(1). DOI: 10.2807/1560-7917.es2015.20.1.20999. View

2.
Brown C, Aranas A, Benenson G, Brunette G, Cetron M, Chen T . Airport exit and entry screening for Ebola--August-November 10, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63(49):1163-7. PMC: 4584540. View

3.
. Announcement: Interim U.S. guidance for monitoring and movement of persons with potential Ebola virus exposure. MMWR Morb Mortal Wkly Rep. 2014; 63(43):984. PMC: 5779474. View

4.
Drazen J, Kanapathipillai R, Campion E, Rubin E, Hammer S, Morrissey S . Ebola and quarantine. N Engl J Med. 2014; 371(21):2029-30. DOI: 10.1056/NEJMe1413139. View

5.
Sunshine G, Pepin D, Cetron M, Penn M . State and Territorial Ebola Screening, Monitoring, and Movement Policy Statements - United States, August 31, 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(40):1145-6. DOI: 10.15585/mmwr.mm6440a4. View